Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6906530 | 0.97 | LMNA (0.35) | THRBLMNA | |
| SCHEMBL1434180 | 0.97 | LMNA (0.35) | THRBLMNA | |
| SCHEMBL1984822 | 0.97 | LMNA (0.35) | THRBLMNA | |
| SCHEMBL6873310 | 0.97 | LMNA (0.35) | THRBLMNA | |
| SCHEMBL6889577 | 0.97 | LMNA (0.35) | THRBLMNA | |
| SCHEMBL866920 | 0.91 | — | — | |
| SCHEMBL28445967 | 0.83 | — | — | |
| SCHEMBL28444858 | 0.81 | THRB (0.32) | THRBLMNA | |
| SCHEMBL28438612 | 0.81 | THRB (0.32) | THRBLMNA | |
| SCHEMBL3058414 | 0.81 | LMNA (0.37) | THRBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116478400-A | Polyimide and diamine monomer containing tetrabiphenyl derivative structure and preparation method thereof | 中山大学 | 2023-07-25 | — | — | CN | claimed |
| CN-116478400-A | Polyimide and diamine monomer containing tetrabiphenyl derivative structure and preparation method thereof | 中山大学 | 2023-07-25 | — | — | CN | disclosed |
| WO-2021153720-A1 | 3-ALKOXY BENZOIC ACID AMIDE DERIVATIVE, AND PEST CONTROL AGENT | クミアイ化学工業株式会社 | 2021-08-05 | — | — | WO | disclosed |
| CN-111566524-A | Optical laminate and display device | 住友化学株式会社 | 2020-08-21 | — | — | CN | disclosed |
| US-7157442-B2 | Antibacterial compound | SANKYO COMPANY, LIMITED (JP) | 2007-01-02 | — | — | US | disclosed |
| EP-1209166-B1 | NOVEL A-500359 DERIVATIVES | SANKYO CO (JP) | 2004-03-31 | — | — | EP | disclosed |
| US-20030171330-A1 | Antibacterial compound | SANKYO COMPANY, LIMITED (JP) | 2003-09-11 | — | — | US | disclosed |
| EP-1209166-A1 | NOVEL A-500359 DERIVATIVES | Sankyo Company, Limited (JP) | 2002-05-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030171330-A1 | Antibacterial compound | TLR1, MPO, O60361 | THRB 3349/4885LMNA 4477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.